{"id":"simvastatin-zocor","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Muscle pain or myalgia"},{"rate":"1-3","effect":"Elevated liver enzymes (ALT/AST)"},{"rate":"2-5","effect":"Headache"},{"rate":"<0.1","effect":"Rhabdomyolysis (rare)"},{"rate":"1-2","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1201391","moleculeType":"Small molecule","molecularWeight":"436.59"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Simvastatin is a statin that competitively inhibits HMG-CoA reductase, blocking the conversion of HMG-CoA to mevalonate in the cholesterol biosynthetic pathway. This leads to decreased hepatic cholesterol production, upregulation of LDL receptors on liver cells, and enhanced clearance of LDL cholesterol from the bloodstream. The net result is significant reduction in serum LDL cholesterol and triglycerides, with modest increases in HDL cholesterol.","oneSentence":"Simvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:08:06.566Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia and mixed dyslipidemia"},{"name":"Primary prevention of coronary heart disease"},{"name":"Secondary prevention of cardiovascular events in patients with established coronary heart disease"}]},"trialDetails":[{"nctId":"NCT07485569","phase":"PHASE1","title":"Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial","status":"NOT_YET_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2026-06-01","conditions":"Thyroid Cancer Stage IV, Anaplastic Thyroid Cancer, Differentiated Thyroid Cancer","enrollment":10},{"nctId":"NCT02968810","phase":"PHASE2","title":"Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-21","conditions":"Cirrhosis, Hepatocellular Carcinoma","enrollment":52},{"nctId":"NCT07392541","phase":"PHASE1, PHASE2","title":"Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-30","conditions":"Advanced Biliary Tract Carcinoma","enrollment":29},{"nctId":"NCT06437574","phase":"PHASE2","title":"Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2024-07-16","conditions":"Prostate Cancer","enrollment":140},{"nctId":"NCT07459972","phase":"PHASE4","title":"Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-03-15","conditions":"Liver Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":22},{"nctId":"NCT07264842","phase":"PHASE2","title":"Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars.","status":"RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2024-06-26","conditions":"Pulpal Necrosis","enrollment":60},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT05586360","phase":"PHASE2","title":"T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-03-11","conditions":"Prostate Cancer","enrollment":36},{"nctId":"NCT05771675","phase":"EARLY_PHASE1","title":"Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2024-10-24","conditions":"Recurrent Acute Pancreatitis, Chronic Pancreatitis","enrollment":90},{"nctId":"NCT07389304","phase":"PHASE1","title":"[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Lipid Profile,Blood Pressure","enrollment":100},{"nctId":"NCT04457089","phase":"EARLY_PHASE1","title":"Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer","status":"COMPLETED","sponsor":"Marc Goodman","startDate":"2021-01-25","conditions":"Recurrent Ovarian Cancer, Platinum-sensitive Ovarian Cancer","enrollment":18},{"nctId":"NCT07378293","phase":"PHASE1","title":"Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Diabete Mellitus, Lipid Profile","enrollment":100},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT04514029","phase":"EARLY_PHASE1","title":"Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel","status":"ACTIVE_NOT_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2020-08-06","conditions":"Lymphoma","enrollment":37},{"nctId":"NCT00858637","phase":"PHASE3","title":"Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-03","conditions":"Chronic Kidney Disease","enrollment":260},{"nctId":"NCT03654053","phase":"PHASE3","title":"Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-10-02","conditions":"Cirrhosis","enrollment":142},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT02675309","phase":"PHASE1","title":"A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2016-02","conditions":"Healthy","enrollment":28},{"nctId":"NCT07213557","phase":"PHASE2","title":"Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2025-12","conditions":"Advanced or Metastatic Gastrooesophageal Carcinoma","enrollment":84},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT05963568","phase":"PHASE3","title":"Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)","status":"NOT_YET_RECRUITING","sponsor":"Northern California Institute of Research and Education","startDate":"2026-01-01","conditions":"Stroke, Medication Adherence","enrollment":680},{"nctId":"NCT07256561","phase":"NA","title":"Antimicrobial and Anti-inflammatory Effects of Simvastatin as an Intracanal Medication","status":"RECRUITING","sponsor":"Hadeer Maher Mostafa Mohamed","startDate":"2025-08-10","conditions":"Endodontically Retard Teeth, Periapical Radiolucency","enrollment":54},{"nctId":"NCT02197234","phase":"PHASE1","title":"Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-12-22","conditions":"Non Small Cell Lung Cancer","enrollment":52},{"nctId":"NCT03889795","phase":"PHASE1","title":"Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Danae Hamouda, MD","startDate":"2019-06-05","conditions":"Advanced Pancreatic Cancer, Advanced Solid Tumor","enrollment":15},{"nctId":"NCT06948747","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-06","conditions":"Healthy Participants","enrollment":49},{"nctId":"NCT07194447","phase":"NA","title":"Effect of Locally Applied Simvastatin Gel on Dental Implant Stability and Marginal Bone Level","status":"COMPLETED","sponsor":"Maha Zuhair","startDate":"2024-10-03","conditions":"Dental Implants , Osseointegration , Marginal Bone Loss , Implant Stability","enrollment":42},{"nctId":"NCT04133792","phase":"PHASE3","title":"Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Annika Bergquist","startDate":"2020-10-01","conditions":"Primary Sclerosing Cholangitis","enrollment":571},{"nctId":"NCT07102979","phase":"NA","title":"Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response","status":"ENROLLING_BY_INVITATION","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-09-01","conditions":"Liver Cirrhosis","enrollment":150},{"nctId":"NCT06858332","phase":"","title":"Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":2382},{"nctId":"NCT05821556","phase":"PHASE2","title":"Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients","status":"RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2023-06-12","conditions":"Adenocarcinoma of the Pancreas","enrollment":240},{"nctId":"NCT03400826","phase":"PHASE2","title":"Effects of Simvastatin on Uterine Leiomyoma Size","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2018-08-20","conditions":"Fibroid Uterus, Fibroid Tumor, Leiomyoma","enrollment":60},{"nctId":"NCT03896217","phase":"PHASE2","title":"Simvastatin in Secondary Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"University College, London","startDate":"2019-05-16","conditions":"Secondary Progressive Multiple Sclerosis","enrollment":40},{"nctId":"NCT07031778","phase":"EARLY_PHASE1","title":"Topic Simvastatin for Bone Regeneration","status":"RECRUITING","sponsor":"Universidad de Granada","startDate":"2025-01-07","conditions":"Dimensional Changes, Bone Density","enrollment":90},{"nctId":"NCT05525013","phase":"NA","title":"Effect of Simvastatin Versus Calcium Hydroxide Intracanal Medications on Post-operative Pain and Interleukin 6 and 8","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-10-01","conditions":"Periapical Periodontitis","enrollment":30},{"nctId":"NCT06431919","phase":"NA","title":"Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2025-06-10","conditions":"Decompensated Cirrhosis, Cirrhotic Cardiomyopathy, Cirrhosis, Liver","enrollment":260},{"nctId":"NCT07003815","phase":"PHASE2","title":"Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer","status":"NOT_YET_RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-06","conditions":"Biliary Tract Cancer, Advanced Cancer","enrollment":62},{"nctId":"NCT00678743","phase":"PHASE4","title":"An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin","status":"COMPLETED","sponsor":"Provident Clinical Research","startDate":"2007-08","conditions":"Dyslipidemias","enrollment":17},{"nctId":"NCT05464810","phase":"EARLY_PHASE1","title":"Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-09-02","conditions":"Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8","enrollment":40},{"nctId":"NCT06879171","phase":"NA","title":"Radiographic and Histomorphometric Assessment for Alveolar Ridge Preservation Using Autogenous Tooth Graft From Extracted Tooth Combined With Simvastatin 1:1 Versus Autogenous Tooth Graft","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-06-10","conditions":"Alveolar Ridge Preservation, Horizontal Alveolar Bone Loss, Vertical Alveolar Bone Loss","enrollment":26},{"nctId":"NCT06925490","phase":"PHASE1","title":"Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-06","conditions":"Irreversible Pulpitis, Primary Teeth, Pulp Disease, Dental","enrollment":50},{"nctId":"NCT04021498","phase":"PHASE3","title":"Simvastatin in the Prevention of Recurrent Pancreatitis","status":"TERMINATED","sponsor":"Enrique de-Madaria","startDate":"2017-09-29","conditions":"Pancreatitis Relapsing","enrollment":83},{"nctId":"NCT06856772","phase":"PHASE4","title":"Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial","status":"NOT_YET_RECRUITING","sponsor":"Tor Biering-Sørensen","startDate":"2025-02-28","conditions":"Cardiovascular Diseases (CVD), Drug Effect, Atherosclerosis Cardiovascular Disease","enrollment":42000},{"nctId":"NCT03324425","phase":"PHASE2","title":"Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor Breast Care Center","startDate":"2020-03-04","conditions":"Breast Cancer Stage IV","enrollment":5},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT06785740","phase":"","title":"Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-11-01","conditions":"Ischemic Stroke, TIA","enrollment":300},{"nctId":"NCT06785727","phase":"PHASE4","title":"StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Prof. dr. Nathalie van der Velde","startDate":"2025-02-01","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":612},{"nctId":"NCT06752889","phase":"NA","title":"Clinical and Radiographic Evaluation of Zinc Oxide Modified 3Mixtatin Versus Zical in Root Canal Treatment of Necrotic Primary Molars.","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-01-01","conditions":"Necrotic Pulp, Primary Teeth","enrollment":34},{"nctId":"NCT01602029","phase":"PHASE2","title":"Randomized Double Blind Placebo Control Study in Patients with Schizophrenia","status":"COMPLETED","sponsor":"Pakistan Institute of Living and Learning","startDate":"2010-08","conditions":"Schizophrenia, Schizoaffective Disorder, Psychosis Not Otherwise Specified","enrollment":303},{"nctId":"NCT04301271","phase":"PHASE2","title":"Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2020-08-13","conditions":"Depressive Disorder, Major, Obesity","enrollment":161},{"nctId":"NCT04971577","phase":"PHASE2, PHASE3","title":"Efficacy of Simvastatin in Alcoholic Liver Fibrosis","status":"RECRUITING","sponsor":"Anna Cruceta","startDate":"2022-02-22","conditions":"Liver Fibrosis, Alcohol Abuse","enrollment":90},{"nctId":"NCT06523465","phase":"PHASE4","title":"Statin Combined with Amlodipine Treats Primary Aldosteronism","status":"RECRUITING","sponsor":"Third Military Medical University","startDate":"2024-09-10","conditions":"Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist","enrollment":180},{"nctId":"NCT05397405","phase":"NA","title":"Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-05-23","conditions":"Intracranial Artery Stenosis","enrollment":180},{"nctId":"NCT06684366","phase":"","title":"Chronic Coronary Syndrome Real Practice and Guidelines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assiut University","startDate":"2024-10-22","conditions":"Coronary Arterial Disease (CAD)","enrollment":300},{"nctId":"NCT04638400","phase":"PHASE4","title":"Anti-inflammatory Effects of Simvastatin","status":"TERMINATED","sponsor":"paresh Dandona","startDate":"2017-05-01","conditions":"Inflammation, Atherosclerosis, Hypercholesterolemia","enrollment":10},{"nctId":"NCT05059626","phase":"PHASE4","title":"Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee","status":"RECRUITING","sponsor":"Penn State University","startDate":"2023-12-01","conditions":"Endometriosis","enrollment":28},{"nctId":"NCT06632834","phase":"PHASE2","title":"Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-08-15","conditions":"Dilated Cardiomyopathy","enrollment":230},{"nctId":"NCT05550415","phase":"PHASE2","title":"The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer","status":"RECRUITING","sponsor":"Indonesia University","startDate":"2022-08-19","conditions":"Triple Negative Breast Cancer, Chemotherapy Effect, Simvastatin Adverse Reaction","enrollment":26},{"nctId":"NCT03131726","phase":"PHASE3","title":"Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)","status":"RECRUITING","sponsor":"Lund University","startDate":"2018-01-26","conditions":"Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy","enrollment":80},{"nctId":"NCT03387670","phase":"PHASE3","title":"Multiple Sclerosis-Simvastatin Trial 2","status":"COMPLETED","sponsor":"University College, London","startDate":"2018-03-28","conditions":"Secondary Progressive Multiple Sclerosis (SPMS)","enrollment":964},{"nctId":"NCT01414192","phase":"","title":"A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-11-15","conditions":"Dyslipidemia, Hypercholesterolemia","enrollment":3215},{"nctId":"NCT00092651","phase":"PHASE3","title":"A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-09","conditions":"Hypercholesterolemia","enrollment":1398},{"nctId":"NCT00541697","phase":"PHASE3","title":"Eze/Simva Switch Study in Diabetics (0653A-807)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-01-19","conditions":"Diabetes Mellitus, Type 2","enrollment":648},{"nctId":"NCT00652717","phase":"PHASE4","title":"Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Cardiovascular Disorder","enrollment":280},{"nctId":"NCT00551876","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-12","conditions":"Diabetes Mellitus, Type 2","enrollment":214},{"nctId":"NCT00651560","phase":"PHASE3","title":"Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11-01","conditions":"Hyperlipidemia","enrollment":167},{"nctId":"NCT00551447","phase":"PHASE3","title":"A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-01","conditions":"Coronary Disease","enrollment":616},{"nctId":"NCT00093899","phase":"PHASE3","title":"A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11","conditions":"Hyperlipidemia, Hypercholesterolemia, Hypertriglyceridemia","enrollment":611},{"nctId":"NCT00650819","phase":"PHASE3","title":"Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-06-01","conditions":"Hypercholesterolemia","enrollment":240},{"nctId":"NCT00092157","phase":"PHASE3","title":"Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-05-01","conditions":"Hypercholesterolemia","enrollment":571},{"nctId":"NCT00552097","phase":"PHASE3","title":"Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-06-01","conditions":"Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II","enrollment":720},{"nctId":"NCT00092664","phase":"PHASE3","title":"An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01","conditions":"Hypercholesterolemia","enrollment":1104},{"nctId":"NCT00090298","phase":"PHASE3","title":"Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-04","conditions":"Hypercholesterolemia","enrollment":2815},{"nctId":"NCT00650663","phase":"PHASE4","title":"Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-10-01","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":247},{"nctId":"NCT00092716","phase":"PHASE3","title":"Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-05","conditions":"Hypercholesterolemia","enrollment":655},{"nctId":"NCT00251576","phase":"PHASE3","title":"Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1999-11-01","conditions":"Acute Coronary Syndrome","enrollment":4497},{"nctId":"NCT00132717","phase":"PHASE3","title":"A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-01-01","conditions":"Hypercholesterolemia","enrollment":450},{"nctId":"NCT00157911","phase":"PHASE3","title":"A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Hypercholerolemia","enrollment":136},{"nctId":"NCT00398294","phase":"PHASE4","title":"To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05-01","conditions":"Hypercholesterolemia","enrollment":30},{"nctId":"NCT00653835","phase":"PHASE4","title":"Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Hypercholesterolaemia, Atherosclerosis","enrollment":153},{"nctId":"NCT00110435","phase":"PHASE3","title":"A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05","conditions":"Type 2 Diabetes Mellitus, Hypercholesterolemia","enrollment":1229},{"nctId":"NCT00652301","phase":"PHASE3","title":"A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-07","conditions":"Cholesterol","enrollment":40},{"nctId":"NCT00651274","phase":"PHASE4","title":"Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-01","conditions":"Atherosclerosis, Hypercholesterolemia, Coronary Heart Disease","enrollment":144},{"nctId":"NCT00389896","phase":"PHASE3","title":"A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-26","conditions":"HDL Cholesterol","enrollment":150},{"nctId":"NCT00092612","phase":"PHASE3","title":"Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":372},{"nctId":"NCT00092599","phase":"PHASE3","title":"Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":410},{"nctId":"NCT00166530","phase":"PHASE4","title":"EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11","conditions":"Atherosclerosis","enrollment":367},{"nctId":"NCT00090168","phase":"PHASE3","title":"Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-01-27","conditions":"Hypercholesterolemia, Atherosclerotic Disease, Coronary Disease","enrollment":435},{"nctId":"NCT00651391","phase":"PHASE3","title":"Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2003-10-01","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":28},{"nctId":"NCT00395603","phase":"PHASE3","title":"Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Cardiovascular Diseases, Diabetes Mellitus","enrollment":550},{"nctId":"NCT06379958","phase":"PHASE1","title":"Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects","status":"RECRUITING","sponsor":"Modern Biosciences Ltd","startDate":"2024-04-08","conditions":"Pharmacokinetics","enrollment":48},{"nctId":"NCT03011931","phase":"EARLY_PHASE1","title":"Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]","status":"COMPLETED","sponsor":"Entero Therapeutics","startDate":"2016-03","conditions":"Celiac Disease","enrollment":40},{"nctId":"NCT06186622","phase":"PHASE1","title":"A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2024-01-02","conditions":"Healthy, Obese, Overweight","enrollment":50},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT02096588","phase":"PHASE2","title":"Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2014-05-20","conditions":"Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer","enrollment":34},{"nctId":"NCT06478940","phase":"PHASE1","title":"3Mixtatin and MTA Vital Pulpotomy in Primary Molars","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-01","conditions":"Pulp Disease, Dental, Deciduous Teeth","enrollment":50},{"nctId":"NCT04973800","phase":"NA","title":"Simvastatin and Emotional Processing (OxSTEP)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-07-05","conditions":"Depression, Inflammation","enrollment":101},{"nctId":"NCT00202878","phase":"PHASE3","title":"IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-10-17","conditions":"Hypercholesterolemia, Myocardial Infarction","enrollment":18144},{"nctId":"NCT00157924","phase":"PHASE4","title":"Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11","conditions":"Hypercholesterolemia","enrollment":190},{"nctId":"NCT00739050","phase":"PHASE4","title":"Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-09-19","conditions":"Systemic Lupus Erythematosus","enrollment":4}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":46,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zocor"],"phase":"marketed","status":"active","brandName":"Simvastatin (Zocor)","genericName":"Simvastatin (Zocor)","companyName":"New York State Psychiatric Institute","companyId":"new-york-state-psychiatric-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Simvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels. Used for Hypercholesterolemia and mixed dyslipidemia, Primary prevention of coronary heart disease, Secondary prevention of cardiovascular events in patients with established coronary heart disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}